ALLMedicine™ Ventilator-associated Pneumonia Center

Apr 30th, 2021 - The aim of this study was to describe the proportion of multidrug-resistant microorganisms (MDROs) involved in ventilator-associated pneumonia (VAP) as the first hospital-acquired infection in 536 adults with restricted risk factors for MDRO-relat...

Apr 24th, 2021 - Staphylococcus aureus remains a common cause of ventilator-associated pneumonia, with little change in incidence over the past 15 years. We aimed to evaluate the efficacy of suvratoxumab, a monoclonal antibody targeting the α toxin, in reducing th...

Apr 22nd, 2021 - We reviewed similarities and differences of ventilator associated pneumonia in Sars-Cov2 infection and with other ARDS. The differences in epidemiology and outcome will be detailed. Possible explanations of differences in pathophysiology of VAP in...

Apr 19th, 2021 - Background: Many trauma centers have empiric treatment algorithms for ventilator-associated pneumonia (VAP) treatment prior to culture results that include antibiotic agents for methicillin-resistant Staphylococcus aureus (MRSA) coverage that can ...

Apr 16th, 2021 - Prompt diagnosis and intervention for ventilator-associated pneumonia (VAP) is critical but can lead to overdiagnosis and overtreatment. We investigated healthcare provider (HCP) perceptions and challenges associated with VAP diagnosis, and we sou...

Sep 11th, 2017 - The most recent European guidelines and task force reports on hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) were published almost 10 years ago. Since then, further randomised clinical trials of HAP and VAP have been c...

Jul 15th, 2016 - It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. IDSA considers adher...

May 17th, 2016 - It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations.

Jul 15th, 2014 - Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update.|2014|Klompas M,Branson R,Eichenwald EC,Greene LR,Howell MD,|standards,diagnosis,prevention & control,adverse effects,

Sep 27th, 2010 - The Association for Professionals in Infection Control and Epidemiology (APIC) began publishing their series of Elimination Guides in 2007. Since then, 9 Elimination Guides have been developed that cover a range of important infection prevention i...

Apr 30th, 2021 - The aim of this study was to describe the proportion of multidrug-resistant microorganisms (MDROs) involved in ventilator-associated pneumonia (VAP) as the first hospital-acquired infection in 536 adults with restricted risk factors for MDRO-relat...

Apr 24th, 2021 - Staphylococcus aureus remains a common cause of ventilator-associated pneumonia, with little change in incidence over the past 15 years. We aimed to evaluate the efficacy of suvratoxumab, a monoclonal antibody targeting the α toxin, in reducing th...

Apr 22nd, 2021 - We reviewed similarities and differences of ventilator associated pneumonia in Sars-Cov2 infection and with other ARDS. The differences in epidemiology and outcome will be detailed. Possible explanations of differences in pathophysiology of VAP in...

Apr 19th, 2021 - Background: Many trauma centers have empiric treatment algorithms for ventilator-associated pneumonia (VAP) treatment prior to culture results that include antibiotic agents for methicillin-resistant Staphylococcus aureus (MRSA) coverage that can ...

Apr 16th, 2021 - Prompt diagnosis and intervention for ventilator-associated pneumonia (VAP) is critical but can lead to overdiagnosis and overtreatment. We investigated healthcare provider (HCP) perceptions and challenges associated with VAP diagnosis, and we sou...

Mar 17th, 2021 - NEW YORK (Reuters Health) - Early tracheotomy placement in critically ill patients is associated with lower ventilator-associated pneumonia (VAP) rates, shorter durations of mechanical ventilation and fewer ICU days, but not with reduced short-ter...

Dec 11th, 2019 - The concept of healthcare-associated pneumonia (HCAP) gained widespread acceptance in 2005 after it was endorsed by an American Thoracic Society (ATS)/Infectious Diseases Society of America (IDSA) guideline. Since then, labeling patients with HCAP...

Nov 19th, 2019 - A 2-day course of prophylactic antibiotic therapy can lower the risk of early ventilator-associated pneumonia (VAP) in cardiac arrest patients, a new study suggests. Investigators compared administration of amoxicillin-clavulanate vs placebo in ad...

Apr 1st, 2019 - A 60-year-old man is admitted for respiratory failure following a massive myocardial infarction. He develops ventilator-associated pneumonia and is treated with cefepime and vancomycin.

Mar 8th, 2019 - SAN DIEGO – A rounding team formed to oversee implementation of a bundle of ICU interventions reduced the incidence of ventilator-associated pneumonia (VAP) and the number of ventilation days, as well as the ICU and hospital length of stay, accord.